BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21621875)

  • 1. Length of stay and charges associated with health care-acquired bloodstream infections.
    Al-Rawajfah OM; Hewitt JB; Stetzer F; Cheema J
    Am J Infect Control; 2012 Apr; 40(3):227-32. PubMed ID: 21621875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-confirmed, health care-associated bloodstream infections in Jordan: a matched cost and length of stay study.
    Al-Rawajfah OM; Cheema J; Hewitt JB; Hweidi IM; Musallam E
    Am J Infect Control; 2013 Jul; 41(7):607-11. PubMed ID: 23332723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
    J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia.
    Eber MR; Laxminarayan R; Perencevich EN; Malani A
    Arch Intern Med; 2010 Feb; 170(4):347-53. PubMed ID: 20177037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF; Chiong JR; Christian R; Lin J
    Hosp Pract (1995); 2012 Feb; 40(1):7-14. PubMed ID: 22406878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with hospital length of stay and hospital charges of motor vehicle crash related hospitalizations among children in the United States.
    Gardner R; Smith GA; Chany AM; Fernandez SA; McKenzie LB
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):889-95. PubMed ID: 17768290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Devriese S; van de Sande S
    Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.
    Williams MD; Braun LA; Cooper LM; Johnston J; Weiss RV; Qualy RL; Linde-Zwirble W
    Crit Care; 2004 Oct; 8(5):R291-8. PubMed ID: 15469571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
    Tong KB; Lau CJ; Murtagh K; Layton AJ; Seifeldin R
    Int J Infect Dis; 2009 Jan; 13(1):24-36. PubMed ID: 18621562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National hospitalization burden associated with spinal cord injuries in the United States.
    Mahabaleshwarkar R; Khanna R
    Spinal Cord; 2014 Feb; 52(2):139-44. PubMed ID: 24276419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial.
    Chiong JR; Kim S; Lin J; Christian R; Dasta JF
    J Med Econ; 2012; 15(2):276-84. PubMed ID: 22111754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
    Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
    J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of nosocomial infections.
    Kilgore ML; Ghosh K; Beavers CM; Wong DY; Hymel PA; Brossette SE
    Med Care; 2008 Jan; 46(1):101-4. PubMed ID: 18162862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic and demographic variability of cost and surgical treatment of idiopathic scoliosis.
    Daffner SD; Beimesch CF; Wang JC
    Spine (Phila Pa 1976); 2010 May; 35(11):1165-9. PubMed ID: 20421853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB; Lee H; Gregson DB; Manns BJ
    J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
    Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
    Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.